Get the Stockscreener App
40.91
12.24%
4.46
Pre-market:
41.45
0.54
+1.32%
Korro Bio Inc stock is traded at $40.91, with a volume of 343.09K.
It is up +12.24% in the last 24 hours and down -14.58% over the past month.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
See More
Previous Close:
$36.45
Open:
$37.12
24h Volume:
343.09K
Relative Volume:
1.53
Market Cap:
$384.18M
Revenue:
-
Net Income/Loss:
$-81.17M
P/E Ratio:
-4.0367
EPS:
-10.1344
Net Cash Flow:
$-82.84M
1W Performance:
+7.40%
1M Performance:
-14.58%
6M Performance:
+130.48%
1Y Performance:
-28.85%
1-Day Range:
$36.01
$42.70
1-Week Range:
$36.01
$42.70
52-Week Range:
$10.29
$76.79
Korro Bio Inc Stock (KRRO) Company Profile
Name
Korro Bio Inc
Sector
Industry
Phone
617-468-1999
Address
60 FIRST STREET, CAMBRIDGE
Compare KRRO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
40.91 | 342.30M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-16-25 | Initiated | Chardan Capital Markets | Buy |
| Jan-10-25 | Initiated | Oppenheimer | Outperform |
| Oct-21-24 | Initiated | Raymond James | Strong Buy |
| Aug-14-24 | Initiated | William Blair | Outperform |
| Mar-28-24 | Reiterated | H.C. Wainwright | Buy |
| Feb-27-24 | Initiated | BMO Capital Markets | Outperform |
| Dec-04-23 | Initiated | H.C. Wainwright | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Nov-10-23 | Initiated | Piper Sandler | Overweight |
| Feb-15-23 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Feb-13-23 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-22-21 | Downgrade | Goldman | Buy → Neutral |
| Jan-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-22-20 | Initiated | B. Riley Securities | Buy |
| Jul-14-20 | Initiated | Oppenheimer | Outperform |
| May-18-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-28-19 | Initiated | Cowen | Outperform |
| Oct-28-19 | Initiated | Goldman | Buy |
| Oct-28-19 | Initiated | JP Morgan | Overweight |
View All
Korro Bio Inc Stock (KRRO) Latest News
Can Korro Bio Inc. stock double in next 5 yearsMarket Movers & AI Optimized Trading Strategy Guides - newser.com
Will Korro Bio Inc. stock recover faster than market2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Automated trading signals detected on Korro Bio Inc.Market Activity Report & Consistent Profit Trading Strategies - newser.com
Trend analysis for Korro Bio Inc. this weekJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com
Why Korro Bio Inc. stock is favored by pension fundsPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Korro Bio’s KRRO-110 Study: A Potential Game-Changer in Genetic Therapy - MSN
Published on: 2025-11-01 04:19:56 - newser.com
Will Korro Bio Inc. stock deliver strong dividend growthWeekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
Why retail investors pile into Korro Bio Inc. stockJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
What high frequency data says about Korro Bio Inc.2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
How to track smart money flows in Korro Bio Inc.2025 Performance Recap & Risk Managed Trade Strategies - newser.com
Risk vs reward if holding onto Korro Bio Inc.Market Activity Report & High Accuracy Buy Signal Tips - newser.com
Clear Street Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - Nasdaq
This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
What makes Korro Bio Inc. stock attractive to growth fundsJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com
Key resistance and support levels for Korro Bio Inc.July 2025 PostEarnings & Detailed Earnings Play Strategies - newser.com
Custom strategy builders for tracking Korro Bio Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Will Korro Bio Inc. stock attract more institutional investorsJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Clear Street initiates Korro Bio stock with Buy rating, $93 price target - Investing.com Canada
Clear Street initiates Korro Bio stock with Buy rating, $93 price target By Investing.com - Investing.com South Africa
What analysts say about Korro Bio Inc stockInflation Impact on Stocks & Free Rapid Return Acceleration - earlytimes.in
Is Korro Bio Inc. stock positioned for long term growthQuarterly Market Review & Low Volatility Stock Recommendations - newser.com
Korro Bio Inc Stock (KRRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Korro Bio Inc Stock (KRRO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):